Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • Atossa Therapeutics News

    1,52 $ 0,00% +0,00 $
    In : 1,4176 € | 25.04.24 22:00:04 Nasdaq aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A2JJ99
    ISIN: US04962H5063
    US-Symbol: ATOS
    Typ: Aktie

    Atossa Therapeutics News

    26.03.24 - PR Newswire
    Thinking about buying stock in Cardiff Oncology, BIOLASE, Akebia Therapeutics, Astera Labs, or Atossa Therapeutics?
    Thinking about buying stock in Cardiff Oncology, BIOLASE, Akebia Therapeutics, Astera Labs, or Atossa Therapeutics? PR Newswire
    20.03.24 - PR Newswire
    Thinking about buying stock in Pixelworks, Backblaze, Praxis Precision Medicines, Scworx, or Atossa Therapeutics?
    Thinking about buying stock in Pixelworks, Backblaze, Praxis Precision Medicines, Scworx, or Atossa Therapeutics? PR Newswire
    30.10.23 - PR Newswire
    Quantum Leap Healthcare Collaborative Initiates Landmark Phase 2 RECAST DCIS Platform Trial to Evaluate Alternative DCIS Treatments with Atossa Therapeutics, Havah Therapeutics, and the Menarini Group
    Quantum Leap Healthcare Collaborative Initiates Landmark Phase 2 RECAST DCIS Platform Trial to Evaluate Alternative DCIS Treatments with Atossa Therapeutics, Havah ...
    11.10.23 - PR Newswire
    Fast-food consumption by adolescent girls may sow the seeds of breast cancer decades later
    Fast-food consumption by adolescent girls may sow the seeds of breast cancer decades later PR Newswire
    04.09.23 - Gurupress
    Atossa Genetics Aktie: Rückgang und skeptische Investoren erwarten Quartalsergebnisse
    Die Atossa Genetics Aktie hat in den letzten 30 Tagen einen Rückgang von -24,53% verzeichnet. Dies zeigt, dass die Anleger möglicherweise skeptisch sind und auf negative ...
    28.06.23 - PR Newswire
    Atossa Therapeutics and Quantum Leap Healthcare Provide Enrollment Update for (Z)-Endoxifen Arm of Ongoing I-SPY 2 Clinical Trial
    Atossa Therapeutics and Quantum Leap Healthcare Provide Enrollment Update for (Z)-Endoxifen Arm of Ongoing I-SPY 2 Clinical Trial PR Newswire
    11.05.23 - PR Newswire
    Physician-Scientist Dr. Steven Quay Provides Recommendations to the United States Preventive Services Task Force on Breast Cancer Screening Policies and Practices
    Physician-​Scientist Dr. Steven Quay Provides Recommendations to the United States Preventive Services Task Force on Breast Cancer Screening Policies and Practices PR Newswire
    21.03.23 - PR Newswire
    Atossa Therapeutics and Quantum Leap Healthcare Announce New Study Arm to Evaluate (Z)-Endoxifen in the Ongoing I-SPY 2 Clinical Trial
    Atossa Therapeutics and Quantum Leap Healthcare Announce New Study Arm to Evaluate (Z)-Endoxifen in the Ongoing I-SPY 2 Clinical Trial PR Newswire
    16.12.21 - PR Newswire
    Physician-Scientist Steven Quay Calls for International Effort to Investigate a Coronavirus discovered in Laos by Institut Pasteur
    Physician-​Scientist Steven Quay Calls for International Effort to Investigate a Coronavirus discovered in Laos by Institut Pasteur The BANAL-236 coronavirus violates 40 years of ...
    30.07.21 - PR Newswire
    Thinking about buying stock in Erytech Pharma, NanoVibronix, Atossa Therapeutics, Allied Healthcare, or Camber Energy?
    Thinking about buying stock in Erytech Pharma, NanoVibronix, Atossa Therapeutics, Allied Healthcare, or Camber Energy? PR Newswire
    26.07.21 - PR Newswire
    Physician-Scientist Steven Quay: Forensic examination of Wuhan Institute of Virology COVID-19 patient specimens from December 2019 reveals extensive laboratory contamination, including evidence of genetic manipulation of the Nipah Virus, a BSL-4 pathogen more lethal than Ebola
    Physician-​Scientist Steven Quay: Forensic examination of Wuhan Institute of Virology COVID-19 patient specimens from December 2019 reveals extensive laboratory contamination, ...
    14.07.21 - PR Newswire
    Thinking about buying stock in Ashford Hospitality Trust, Clovis Oncology, Exela Technologies, Wipro, or Atossa Therapeutics?
    Thinking about buying stock in Ashford Hospitality Trust, Clovis Oncology, Exela Technologies, Wipro, or Atossa Therapeutics? PR Newswire
    02.07.21 - PR Newswire
    Thinking about buying stock in Provention Bio, Virgin Galactic, Staffing 360 Solutions, Atossa Therapeutics, or Marin Software?
    Thinking about buying stock in Provention Bio, Virgin Galactic, Staffing 360 Solutions, Atossa Therapeutics, or Marin Software? PR Newswire
    30.06.21 - PR Newswire
    Thinking about buying stock in Check Cap, ContextLogic, Marin Software, Atossa Therapeutics, or Altimmune?
    Thinking about buying stock in Check Cap, ContextLogic, Marin Software, Atossa Therapeutics, or Altimmune? PR Newswire
    25.06.21 - PR Newswire
    Thinking about buying stock in Atossa Therapeutics, ContextLogic, Nokia, Canopy Growth Corp, or Marin Software?
    Thinking about buying stock in Atossa Therapeutics, ContextLogic, Nokia, Canopy Growth Corp, or Marin Software? PR Newswire
    23.06.21 - PR Newswire
    Thinking about buying stock in Acasti Pharma, Globalstar, ContextLogic, Atossa Therapeutics, or Ideanomics?
    Thinking about buying stock in Acasti Pharma, Globalstar, ContextLogic, Atossa Therapeutics, or Ideanomics? PR Newswire
    22.06.21 - PR Newswire
    Thinking about buying stock in vTv Therapeutics, Score Media and Gaming, Bio-Path Holdings, Anavex Life Sciences, or Atossa Therapeutics?
    Thinking about buying stock in vTv Therapeutics, Score Media and Gaming, Bio-Path Holdings, Anavex Life Sciences, or Atossa Therapeutics? PR Newswire
    21.06.21 - PR Newswire
    Thinking about buying stock in MediciNova, Torchlight Energy, Atossa Therapeutics, Globus Maritime, or ContextLogic?
    Thinking about buying stock in MediciNova, Torchlight Energy, Atossa Therapeutics, Globus Maritime, or ContextLogic? PR Newswire
    09.06.21 - PR Newswire
    Thinking about buying stock in BlackBerry, Atossa Therapeutics, UWM Holdings, Farmmi, or Root?
    Thinking about buying stock in BlackBerry, Atossa Therapeutics, UWM Holdings, Farmmi, or Root? PR Newswire
    08.06.21 - PR Newswire
    Thinking about buying stock in BlackBerry, Sonim Technologies, Atossa Therapeutics, Clean Energy Fuels, or Tilray?
    Thinking about buying stock in BlackBerry, Sonim Technologies, Atossa Therapeutics, Clean Energy Fuels, or Tilray? PR Newswire

    Newssuche

    Videos

    newspaper
    25.04.24 +21,95%
    Technical Trading: S&P 500 Short Chance
    S&P 500 Short Typ: Turbo Open End WKN: NG8FUZ Hebel: 31 Laufzeit: OpenEnd Einstieg: Market ... Mehr »